S. Hibbitts
- Immunology top 5%
- Molecular Biology
- Oncology top 10%
- Radiology, Nuclear Medicine and Imaging
- Epidemiology
- Co-authors
- Craig L. SlingluffWilliam W. GroshGina R. PetroniPatrice Y. NeeseGalina V. YamshchikovJames W. PattersonKimberly A. Chianese‐BullockDonna H. Deacon
- Topics
- vaccines and immunoinformatics approaches (9 papers)Immunotherapy and Immune Responses (9 papers)T-cell and B-cell Immunology (4 papers)
- Cited by
- ImmunologyOncologyMolecular Biology
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
S. Hibbitts
13 papers receiving 843 citations
Peers
Comparison fields: 5 of 56
- Immunology 757
- Molecular Biology 474
- Oncology 420
- Radiology, Nuclear Medicine and Imaging 69
- Epidemiology 55
Countries citing papers authored by S. Hibbitts
This map shows the geographic impact of S. Hibbitts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Hibbitts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Hibbitts more than expected).
Fields of papers citing papers by S. Hibbitts
This network shows the impact of papers produced by S. Hibbitts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Hibbitts. The network helps show where S. Hibbitts may publish in the future.
Co-authorship network of co-authors of S. Hibbitts
This figure shows the co-authorship network connecting the top 25 collaborators of S. Hibbitts. A scholar is included among the top collaborators of S. Hibbitts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Hibbitts. S. Hibbitts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 24 | |
| 3 | 6 | |
| 4 | 9 | |
| 5 | 19 | |
| 6 | 133 | |
| 7 | 102 | |
| 8 | 13 | |
| 9 | 111 | |
| 10 | 2 | |
| 11 | 5 | |
| 12 | 252 | |
| 13 | Phase I trial of a melanoma vaccine with gp100(280-288) peptide and tetanus helper peptide in adjuvant: immunologic and clinical outcomes. | 183 |
About S. Hibbitts
S. Hibbitts is a scholar working on Immunology, Microbiology and Molecular Biology, having authored 13 papers that have together received 861 indexed citations. Recurring topics across this work include vaccines and immunoinformatics approaches (9 papers), Immunotherapy and Immune Responses (9 papers) and T-cell and B-cell Immunology (4 papers). The work is most often cited by research in Immunology (757 citations), Oncology (420 citations) and Molecular Biology (474 citations). S. Hibbitts has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Craig L. Slingluff, William W. Grosh, Gina R. Petroni, Patrice Y. Neese, Galina V. Yamshchikov, James W. Patterson, Kimberly A. Chianese‐Bullock, Donna H. Deacon, Elizabeth M. H. Woodson and Víctor H. Engelhard. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Immunology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.